U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907913) titled 'SLAMF1 Gene Expression in Ankylosing Spondylitis' on Oct. 26.
Brief Summary: This cross-sectional study aims to evaluate SLAMF1 gene expression levels in patients with ankylosing spondylitis compared with healthy controls.
Study Start Date: Oct. 30
Study Type: OBSERVATIONAL
Condition:
Ankylosing Spondylitis
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Mennat-Allah Khaled Tolba Abdelraheem, Assiut University
Disclaimer: Curated by HT Syndication....